Synageva BioPharma Inactive 10-Q2004 Q1 Quarterly report

Filed: 7 May 04, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Good

New words: age, bill, capped, claim, convenient, discount, estate, evolving, expenditure, extend, extended, formulation, headcount, hold, kit, merger, network, note, original, paragraph, pension, postretirement, profile, pursuit, put, real, realize, resolution, retail, revised, shipped, source, spend, spouse, structure, substituted, suggest, technical, tolerability, TORO, trend, twelve, week

Removed: accumulation, activity, added, administered, allergic, allocated, allocation, antiviral, appetite, assumption, bacterial, balance, baseline, broader, brought, bruising, building, buying, case, cell, Center, combined, complex, component, Concurrently, confidence, consideration, constipation, constraint, construction, continually, continuity, converted, corrective, count, cubic, cure, cycle, decline, demonstrated, depreciate, depression, detail, detailed, Determination, determine, diarrhea, difficult, discomfort, discontinuation, discontinued, disposal, elevated, enhance, equate, established, evaluate, existence, exit, expanded, expansion, expensive, experiencing, expiration, fatigue, February, fever, fill, forward, frequent, frequently, generated, half, hedging, high, historically, human, hypersensitivity, II, immune, improved, incidence, increasingly, Indexed, injection, insomnia, installation, intensity, intent, internationally, Iraq, itching, judged, killed, Korea, launched, lead, leased, letter, likelihood, limiting, list, liver, local, low, maintained, making, maximize, median, metric, mild, millimeter, moderate, move, multiple, muscle, nausea, NDA, negotiated, observed, opportunistic, output, pack, pain, passage, percent, percentage, peripheral, pilot, pipeline, plant, pneumonia, potent, Potentially, pressure, principle, projected, prudent, purification, rare, rash, reaction, receiving, recent, recently, rechallenge, recurred, renewal, represent, resistant, responsible, restoration, restricted, Restructuring, RTI, scientific, seek, selected, separate, separation, setting, settle, settlement, Simple, site, Stated, statistically, step, studied, study, suppression, surprisingly, synthetic, system, tangible, target, targeted, Termination, topline, track, treated, unchanged, unclear, underlying, undertaken, validation, variety, vitro, vomiting, wide, York

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Synageva BioPharma similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Trimeris, Inc. (the “Company”) for the quarterly period ending March 31, 2004 as filed with Securities and Exchange Commission on the date hereof (the “Report”), I, Dani P. Bolognesi, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ DANI P. BOLOGNESI

Dani P. Bolognesi

Chief Executive Officer

May 7, 2004

The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the Report or as a separate disclosure document.

A signed original of this written statement required by § 906 has been provided to Trimeris, Inc. and will be retained by Trimeris, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.